Search
Genetic analysis reveals biomarkers and possible drug targets for malignant peripheral nerve sheath tumors.
In an effort to improve patients’ response to immunotherapy, MSK researchers have studied how microorganisms in the gut affect outcomes in people receiving CAR T therapy.
Researchers discover how immune cells called macrophages regulate whether fat is stored or burned.
A multi-institution team co-led by MSK researchers has pinpointed what could be the early genetic origins of breast cancer.
New MSK research identifies new cancer-specific targets for T cell receptor immunotherapy approaches; sheds light on a critical process in sexual reproduction; describes how regulatory T cells help prevent intestinal inflammation; and uncovers how the spleen helps natural killer immune cells adapt to new threats.
New MSK research investigates how pancreatic cancer cells regulate their genome to avoid immune attack; shows promise against glioblastoma in mouse models; and develops a new method to study cancer evolution.
An innovative collaboration between basic scientists and clinical researchers has led to a promising new drug for AML.
Memorial Sloan Kettering is sad to note the passing on May 12 of Stephen Sternberg, at the age of 100. Dr. Sternberg spent his entire career at MSK as a surgical pathologist. Widely known as a leader in the field of pathology and highly regarded for his expertise, he was also greatly respected as an editor of major national publications, which garnered him a broad, devoted following around the world.
Moritz Kircher, MD, PhD, has been selected by the directors of the Dana Foundation as a Dana Neuroscience Scholar.
MSK patients that need urgent care may receive care closer to home. That’s when MSK's 34 Shared Care nurses — led by Carol Gemignani — step in.